SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010134
Filing Date
2024-03-15
Accepted
2024-03-15 17:01:09
Documents
21
Period of Report
2024-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 65377
2 ex10-1.htm EX-10.1 623749
3 ex10-2.htm EX-10.2 137878
4 ex10-3.htm EX-10.3 109848
5 ex10-4.htm EX-10.4 241236
6 ex10-5.htm EX-10.5 155231
7 ex10-6.htm EX-10.6 91883
  Complete submission text file 0001493152-24-010134.txt   1915579

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20240313.xsd EX-101.SCH 3872
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20240313_def.xml EX-101.DEF 26769
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20240313_lab.xml EX-101.LAB 37003
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20240313_pre.xml EX-101.PRE 25393
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5943
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 24755742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)